Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EACR 2012 /
Understanding the mechanisms of breast cancer resistance

7th - 10th Jul 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.07.12
Views: 2866

Prof Jos Jonkers – Netherlands Cancer Institute, Amsterdam, Netherlands

Prof Jos Jonkers talks to ecancer.tv about the use of mouse models to understand the mechanisms underlying breast cancer resistance.

Research into BRCA positive breast cancer in mice has shown that resistance can result from the reactivation of the BRCA mutation, however there are likely to be many ways that resistance can develop.

Prof Jonkers explains how this research could translate into clinical benefits to both BRCA mutated breast cancer and other types of tumour.


Breast · Biology · EACR 2012

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation